Alvotech (ALVOW) Competitors $2.34 +0.09 (+4.00%) As of 02/21/2025 03:17 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate Alvotech (NASDAQ:ALVOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk. Does the media prefer ALVOW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Alvotech. 180 Life Sciences' average media sentiment score of 1.38 beat Alvotech's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Alvotech Neutral 180 Life Sciences Positive Does the MarketBeat Community prefer ALVOW or ATNFW? Alvotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlvotechN/AN/A180 Life SciencesN/AN/A Which has higher valuation & earnings, ALVOW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$391.87MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is ALVOW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets AlvotechN/A N/A N/A 180 Life Sciences N/A N/A N/A Summary180 Life Sciences beats Alvotech on 2 of the 3 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVOW vs. The Competition Export to ExcelMetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.35B$5.84B$9.14BDividend YieldN/A2.92%4.75%3.85%P/E RatioN/A4.2726.0419.11Price / SalesN/A733.09447.4676.36Price / CashN/A10.2538.0134.83Price / BookN/A7.507.644.62Net IncomeN/A$20.70B$3.18B$245.85M7 Day Performance-4.49%-0.04%-2.00%-2.61%1 Month Performance-23.28%0.08%-0.44%-2.14%1 Year Performance-42.93%98.03%16.44%12.98% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOWAlvotechN/A$2.34+4.0%N/A-46.2%$0.00$391.87M0.004Gap UpATNFW180 Life SciencesN/A$0.01-9.8%N/A+51.5%$0.00N/A0.007News CoverageGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03+7.6%N/A-13.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.10-35.3%N/A+138.5%$0.00$40,633.000.0040Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05-7.2%N/A-54.4%$0.00N/A0.004BFRIWBiofronteraN/A$0.06-6.3%N/A+254.1%$0.00$35.36M0.0070High Trading VolumeBTMDWbioteN/A$0.50flatN/A-46.2%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12+22.4%N/A-92.9%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.07+14.3%N/A+120.8%$0.00$48.20M0.00220Gap UpCINGWCingulateN/A$0.04-27.3%N/A+102.5%$0.00N/A0.0020Gap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALVOW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALVOW Stock Alerts